Evaluation of Cardiac Function Index as Measured by Transpulmonary Thermodilution as an Indicator of Left Ventricular Ejection Fraction in Cardiogenic Shock
Table 1
Patient characteristics ().
Sex ratio
1.2
Men (; %)
19
(54.3%)
Age (years; SD)
66
±16
Underlying cardiovascular disease:
(i) Preexisting cardiomyopathy (; %)
21
(60%)
LVEF (%; SD)
39.7
±14
(ii) Chronic atrial fibrillation (; %)
11
(31.5%)
SAPSII (; SD)
54
±21
Causes of cardiogenic shock: (; %)
(i) Acute myocardial infarction
15
(42.9%)
(ii) End-stage cardiomyopathy
6
(17.1%)
(iii) Treatment toxicity (chemotherapy)
5
(14.3%)
(iv) Myocarditis
2
(5.7%)
(v) Complex heart rhythm disorder
2
(5.7%)
(vi) Thyrotoxicosis
1
(2.9%)
(vii) Unknown
4
(11.4%)
Need for life support techniques in ICU: (; %)
(i) Renal replacement therapy
12
(34.3%)
(ii) Mechanical ventilation
22
(62.8%)
(iii) Norepinephrine use
25
(71%)
(iv) Epinephrine use
1
(2.8%)
(v) Dobutamine use
35
(100%)
Mortality in the ICU (; %)
19
(54%)
LVEF: left ventricular ejection function; SAPSII: simplified acute physiology score II; ICU: intensive care unit.
